Shinji Kuroda
- Biotechnology top 1%
- Cancer Research and Treatments 31
- Gastroenterology top 2%
- Gastrointestinal Tumor Research and Treatment 12
- Oncology top 5%
- CAR-T cell therapy research 10
- Genetics top 5%
- Virus-based gene therapy research 32
-
- Gastric Cancer Management and Outcomes 26
- Metastasis and carcinoma case studies 10
-
- Esophageal and GI Pathology 11
-
- RNA Interference and Gene Delivery 9
- Co-authors
- Toshiyoshi FujiwaraShunsuke KagawaSatoru KikuchiHiroshi TazawaMasahiko NishizakiYasuo UrataKazuhiro NomaRyuichi Yoshida
- Journals
- Journal of Clinical Investigation (1 paper)Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- JapanUnited StatesMalaysia
In The Last Decade
Shinji Kuroda
131 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 106
- Biotechnology 341
- Gastroenterology 174
- Oncology 759
- Genetics 551
- Pulmonary and Respiratory Medicine 549
Countries citing papers authored by Shinji Kuroda
This map shows the geographic impact of Shinji Kuroda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinji Kuroda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinji Kuroda more than expected).
Fields of papers citing papers by Shinji Kuroda
This network shows the impact of papers produced by Shinji Kuroda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinji Kuroda. The network helps show where Shinji Kuroda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shinji Kuroda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 13 | |
| 5 | 2021 | 26 | |
| 6 | 2020 | 105 | |
| 7 | [Novel Therapeutic Strategy for Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer]. | 2017 | 3 |
| 8 | 2017 | 9 | |
| 9 | 2015 | 18 | |
| 10 | 2014 | 22 | |
| 11 | 2013 | 64 | |
| 12 | 2010 | 61 | |
| 13 | 2009 | 40 | |
| 14 | 2009 | 16 | |
| 15 | 2006 | 12 | |
| 16 | 2001 | 11 | |
| 17 | 2001 | 15 | |
| 18 | Del/ins polymorphism in DGCR6 gene in chromosome 22 and schizophrenia | 2000 | 1 |
| 19 | Association between schizoprenia and a polymorphism of cytosolic phospholipase A2 gene | 2000 | 1 |
| 20 | 2000 | 27 |
About Shinji Kuroda
Shinji Kuroda is a scholar working on Biotechnology, Gastroenterology and Oncology, having authored 140 papers that have together received 2.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (32 papers), Cancer Research and Treatments (31 papers), Gastric Cancer Management and Outcomes (26 papers), Gastrointestinal Tumor Research and Treatment (12 papers), Esophageal and GI Pathology (11 papers), Metastasis and carcinoma case studies (10 papers), CAR-T cell therapy research (10 papers) and RNA Interference and Gene Delivery (9 papers). The work is most often cited by research in Biotechnology (341 citations), Gastroenterology (174 citations) and Oncology (759 citations). Shinji Kuroda has collaborated with scholars based in Japan, United States and Malaysia. Frequent co-authors include Toshiyoshi Fujiwara, Shunsuke Kagawa, Satoru Kikuchi, Hiroshi Tazawa, Masahiko Nishizaki, Yasuo Urata, Kazuhiro Noma, Ryuichi Yoshida, Yasuhiro Shirakawa and Kazuya Kuwada. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.